In today's world, Healthcare Associated Infections (HAI) such as MRSA or Staph, and treating and preventing wounds (such as diabetic ulcers or pressure ulcers) are significant global issues. In the U.S. alone the annual cost of HAIs is over $28B, claiming over 100,000 lives. And globally, more than $14B is spent on wound care products with over 5mil individuals in the U.S. suffering from a chronic wound.
Cupron is working with partners to address these and other significant healthcare issues. Therefore, for the medical marketplace we are focused on working with our business partners in projects designed to 1) to help reduce HAIs (or nosocomial infections) and related costs in healthcare facilities, and 2) to help improve healing/quality of life for specific patient group. By integrating the proven antimicrobial protection, as well as the skin enhancement properties of copper into a wide range of health care and consumer applications.
Healthcare Associated Infections (HAIs).
Cupron Technology can be embedded in a variety of woven and non-woven fabrics and other polymeric products for various health care applications
Wound Healing Potential
Cupron Technology has the potential to help reduce healthcare expenses by improving the healing of difficult wounds / skin conditions, by preventing certain wounds / skin conditions from occurring, and by reducing medications required during the healing process. Cupron Technology can be embedded in a variety of potential woven and non-woven fabrics to enhance skin health and wound closure: Compression garments & sleeves, Diabetic socks, anti-fungal socks, wound care products( gauze, advanced dressings, bandages, sutures).
We encourage you to contact us for additional detailed information about our clinical studies for various medical applications.